Yazar "Jerusalem, Guy" için listeleme
-
Genomic markers of response to monotherapy abemaciclib in the nextMONARCH 1 study
Hamilton, Erika P.; Cortes, Javier; Jerusalem, Guy; Kaufman, Peter A.; Ozyilkan, Ozgur; Hegg, Roberto; Litchfield, Lacey M.; Wang, Hong; Graham, Hillary T.; Wjayawardana, Sameera R.; Jansen, Valerie M.; Martin, Miguel (2020) -
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR +, HER2-metastatic breast cancer
Hamilton, Erika; Cortes, Javier; Ozyilkan, Ozgur; Chen, Shin-Cheh; Petrakova, Katarina; Manikhas, Aleksey; Jerusalem, Guy; Hegg, Roberto; Huober, Jens; Zhang, Wei; Chen, Yanyun; Martin, Miguel (2022)Purpose Resistance to endocrine therapy poses a major clinical challenge for patients with hormone receptor-positive (HR +), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). We ... -
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer
Hamilton, Erika; Cortes, Javier; Ozyilkan, Ozgur; Chen, Shin Cheh; Petrakova, Katarina; Manikhas, Aleksey; Jerusalem, Guy; Hegg, Roberto; Huober, Jens; Chapman, Sonya C.; Lu, Yi; Hardebeck, Molly C.; Bear, Melissa M.; Johnston, Erica L.; Martin, Miguel (2021)nextMONARCH investigated abemaciclib monotherapy and abemaciclib combined with tamoxifen. Patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer (MBC) were treated ...